NextCure, Inc. (NXTC)
NASDAQ: NXTC · IEX Real-Time Price · USD
1.500
0.00 (0.00%)
Jul 2, 2024, 4:00 PM EDT - Market closed
NextCure Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for NextCure stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 300.00% from the current stock price of 1.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 3, 2024.
Analyst Ratings
The average analyst rating for NextCure stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +433.33% | Jun 3, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +433.33% | May 31, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +433.33% | May 3, 2024 |
Needham | Needham | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +166.67% | May 3, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $8 | Strong Buy | Maintains | $5 → $8 | +433.33% | Mar 22, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.77
from -2.25
EPS Next Year
-1.81
from -1.77
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | 7.4M | 42.5M |
Avg | n/a | n/a | n/a | 3.6M | 41.3M |
Low | n/a | n/a | n/a | n/a | 39.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 1,091.2% |
Avg | - | - | - | - | 1,057.1% |
Low | - | - | - | - | 1,011.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.70 | -1.56 | -1.05 | -0.65 | -0.51 |
Avg | -1.77 | -1.81 | -1.02 | -0.72 | -0.50 |
Low | -1.82 | -1.99 | -0.98 | -0.78 | -0.48 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.